1
|
Murphy KD, O' Mahony C, McCarthy M, Saab MM, Barbosa TM, Fleming A, Cotter P, Noonan B, Breen E, Carroll G, De Frein A, Heckmann P, Triggs M, Sahm L. Quality assurance standards and their use in the preparation of parenteral systemic anticancer therapy products in healthcare establishments: a scoping review. Eur J Hosp Pharm 2024; 31:88-93. [PMID: 37879730 PMCID: PMC10895183 DOI: 10.1136/ejhpharm-2023-003922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 10/03/2023] [Indexed: 10/27/2023] Open
Abstract
OBJECTIVES The use of parenteral systemic anticancer therapy (SACT) has led to improved cancer survival. A quality assurance (QA) system of the aseptic compounding process is necessary to ensure safe and consistent production of parenteral SACT. This scoping review identifies international evidence and practice relating to QA standards in the preparation of parenteral SACT in healthcare establishments. METHODS Standards relating to aseptic compounding in hospital pharmacies and literature exploring the aseptic compounding of parenteral SACT were included. Literature relating to the non-aseptic compounding of medicines and records specific to sterile manufacturing in industrial settings were excluded. A search of several electronic databases, trial registries, the grey literature and websites of key European hospital pharmacy groups and accreditation bodies was conducted on 16 March 2022. A narrative discussion was performed by country, and content analysis of articles was conducted. RESULTS Thirty-seven records were included. Standards reviewed covered the work environment, the preparation process and the safety of the workers who are potentially exposed to hazardous chemicals. It was a common practice to include frequent audits to ensure adherence to standards. Some standards also recommended external inspections to allow for further learnings. Periodic reviews are encouraged to ensure standards maintain relevance. National standards of the countries reviewed were based on international standards, with minor adaptations for local conditions. CONCLUSIONS The main limitation of this review is that it is limited to countries with a high human development index. The review shows that the use of an internationally recognised standard as a basis for national standards is best practice, and will allow for relevance into the future.
Collapse
Affiliation(s)
- Kevin D Murphy
- School of Pharmacy, University College Cork, Cork, Ireland
| | - Cian O' Mahony
- School of Pharmacy, University College Cork, Cork, Ireland
| | - Megan McCarthy
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | - Mohamad M Saab
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | | | - Aoife Fleming
- School of Pharmacy, University College Cork, Cork, Ireland
- Department of Pharmacy, Mercy University Hospital, Cork, Ireland
| | - Patrick Cotter
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | - Brendan Noonan
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | - Elizabeth Breen
- National Cancer Control Programme, Health Service Executive, Dublin, Ireland
| | - Grant Carroll
- National Cancer Control Programme, Health Service Executive, Dublin, Ireland
| | - AnneMarie De Frein
- National Cancer Control Programme, Health Service Executive, Dublin, Ireland
| | - Patricia Heckmann
- National Cancer Control Programme, Health Service Executive, Dublin, Ireland
| | - Margaret Triggs
- National Cancer Control Programme, Health Service Executive, Dublin, Ireland
| | - Laura Sahm
- School of Pharmacy, University College Cork, Cork, Ireland
- Department of Pharmacy, Mercy University Hospital, Cork, Ireland
| |
Collapse
|
2
|
Coutsouvelis J, Adams J, Bortz H, Chau M, Chiang K, Foo J, Ibrahim K, Kerr K, O'Connor S, Powell M, Rowan G, Siderov J, Tey A, Tran J, Vasileff H, Munro C. Standard of practice in oncology and haematology for pharmacy services. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2020. [DOI: 10.1002/jppr.1686] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- John Coutsouvelis
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Alfred Health Melbourne Australia
- Centre Medication Use and Safety Monash University Parkville Australia
| | - Julie Adams
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- View Health Pty Ltd; chemo@home Pty Ltd West Perth Australia
| | - Hadley Bortz
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Alfred Health Melbourne Australia
| | - Maggie Chau
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Melbourne Health Parkville Australia
| | - Karen Chiang
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Melbourne Health Parkville Australia
- St Vincent's Hospital Fitzroy Australia
| | - Josephine Foo
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Eastern Health Melbourne Australia
| | - Karim Ibrahim
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- St Vincent's Hospital Darlinghurst Australia
- St Vincent's Clinical School University of NSW Sydney Australia
| | - Kimberley‐Ann Kerr
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- SA Pharmacy Lyell McEwin Hospital Elizabeth Vale Australia
| | - Shaun O'Connor
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- St Vincent's Hospital Fitzroy Australia
| | - Michael Powell
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Gold Coast Health Gold Coast University Hospital Southport Australia
| | - Gail Rowan
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Peter MacCallum Cancer Centre Melbourne Australia
| | - Jim Siderov
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Austin Health Heidelberg Australia
| | - Amanda Tey
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Monash Health Clayton Australia
| | - Jenny Tran
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- Cancer Institute NSW Eveleigh Australia
| | - Hayley Vasileff
- Oncology and Haematology Standard of Practice Working Group The Society of Hospital Pharmacists of Australia Collingwood Australia
- SA Pharmacy Women's and Children's Hospital North Adelaide Australia
| | - Courtney Munro
- The Society of Hospital Pharmacists of Australia Collingwood Australia
| |
Collapse
|
3
|
Slobodian P, Challen J, Ching M, Hong E, Nikolajevic‐Sarunac J, Shum B, Vosk C, Munro C. Standard of practice in clinical trials for pharmacy services. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2020. [DOI: 10.1002/jppr.1676] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Peter Slobodian
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- Royal Adelaide Hospital Pharmacy Central Adelaide Local Health Network SA Pharmacy Adelaide Australia
| | - June Challen
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- The Queen Elizabeth Hospital Central Adelaide Local Health Network Woodville Australia
| | | | - Eugenia Hong
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- Melbourne Health Parkville Australia
| | - Jasminka Nikolajevic‐Sarunac
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- John Hunter Hospital New Lambton Heights Australia
| | - Brenda Shum
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- Sir Charles Gairdner Hospital Nedlands Australia
| | - Claire Vosk
- Clinical Trials Leadership Committee The Society of Hospital Pharmacists of Australia Collingwood Australia
- Monash Health Clayton Australia
| | - Courtney Munro
- The Society of Hospital Pharmacists of Australia Collingwood Australia
| |
Collapse
|
4
|
Bernabeu-Martínez MA, Ramos Merino M, Santos Gago JM, Álvarez Sabucedo LM, Wanden-Berghe C, Sanz-Valero J. Guidelines for safe handling of hazardous drugs: A systematic review. PLoS One 2018; 13:e0197172. [PMID: 29750798 PMCID: PMC5947890 DOI: 10.1371/journal.pone.0197172] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Accepted: 04/27/2018] [Indexed: 12/12/2022] Open
Abstract
Objective To review the scientific literature related to the safe handling of hazardous drugs (HDs). Method Critical analysis of works retrieved from MEDLINE, the Cochrane Library, Scopus, CINHAL, Web of Science and LILACS using the terms "Hazardous Substances", "Antineoplastic Agents" and "Cytostatic Agents", applying "Humans" and "Guidelines" as filters. Date of search: January 2017. Results In total, 1100 references were retrieved, and from those, 61 documents were selected based on the inclusion and exclusion criteria: 24 (39.3%) documents related to recommendations about HDs; 27 (44.3%) about antineoplastic agents, and 10 (33.3%) about other types of substances (monoclonal antibodies, gene medicine and other chemical and biological agents). In 14 (23.3%) guides, all the stages in the manipulation process involving a risk due to exposure were considered. Only one guide addressed all stages of the handling process of HDs (including stages with and without the risk of exposure). The most described stages were drug preparation (41 guides, 67.2%), staff training and/or patient education (38 guides, 62.3%), and administration (37 guides, 60.7%). No standardized informatics system was found that ensured quality management, traceability and minimization of the risks associated with these drugs. Conclusions Most of the analysed guidelines limit their recommendations to the manipulation of antineoplastics. The most frequently described activities were preparation, training, and administration. It would be convenient to apply ICTs (Information and Communications Technologies) to manage processes involving HDs in a more complete and simpler fashion.
Collapse
Affiliation(s)
- Mari A. Bernabeu-Martínez
- Department of Public Health and History of Science, School of Medicine, Miguel Hernandez University, Elche, Spain
| | - Mateo Ramos Merino
- Department of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain
| | - Juan M. Santos Gago
- Department of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain
| | - Luis M. Álvarez Sabucedo
- Department of Telematics Engineering, Telecommunication Engineering School of the University of Vigo, Vigo, Spain
| | - Carmina Wanden-Berghe
- Health and Biomedical Research Institute of Alicante, University General Hospital of Alicante, Alicante, Spain
| | - Javier Sanz-Valero
- Department of Public Health and History of Science, School of Medicine, Miguel Hernandez University, Elche, Spain
- * E-mail:
| |
Collapse
|
5
|
Mathias PI, MacKenzie BA, Toennis CA, Connor TH. Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries. J Oncol Pharm Pract 2017; 25:148-162. [PMID: 28841099 DOI: 10.1177/1078155217726160] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
PURPOSE A survey of guidelines and current practices was conducted to examine the safe handling procedures for antineoplastic and other hazardous drugs that are used in 24 countries including the Americas, Europe, the Mideast, Far East, and Australia. METHODS Subject experts were asked to complete a brief survey regarding safe handling guidelines and practices for hazardous drugs in their countries. Questions addressed practices for handling monoclonal antibodies, the use of closed-system transfer devices, medical surveillance practices, and measurements of compliance with existing guidelines. RESULTS Responses from 37 subject experts representing 24 countries revealed considerable variation in the content and scope of safe handling guidelines and pharmacy practices among the participating countries. Guidelines in the majority of countries used the term "cytotoxics," while others referred to "hazardous" or "antineoplastic" drugs. The International Society of Oncology Pharmacy Practice standard was cited by six countries, and five cited the National Institute for Occupational Safety and Health Alert. Others cited international guidelines other than International Society of Oncology Pharmacy Practice, or they have created their own guidelines. Approximately half reported that their guidelines were mandatory under federal, state, or provincial legislation. Only 11 countries reported that monoclonal antibodies were covered in their guidelines. Closed-system drug-transfer devices are widely used, but were not specifically recommended in four countries, while one country required their use. Medical surveillance programs are in place in 20 countries, but only in The Netherlands is surveillance mandatory. Nine countries reported that they have completed recent updates or revisions of guidelines, and the measures for their adoption have been initiated. CONCLUSIONS Although the overall goals in the participating countries were similar, the approaches taken to assure safe handling of hazardous drugs varied considerably in some cases.
Collapse
Affiliation(s)
- Patricia I Mathias
- Robert A. Taft Laboratories, National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, Cincinnati, USA
| | - Barbara A MacKenzie
- Robert A. Taft Laboratories, National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, Cincinnati, USA
| | - Christine A Toennis
- Robert A. Taft Laboratories, National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, Cincinnati, USA
| | - Thomas H Connor
- Robert A. Taft Laboratories, National Institute for Occupational Safety and Health, U.S. Department of Health and Human Services, Cincinnati, USA
| |
Collapse
|
6
|
Section 1 — Introduction. J Oncol Pharm Pract 2016. [DOI: 10.1177/10781552070130030102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
7
|
Hawasli RSD, Kayyali R, Barton S, Osei-Barnieh G, Nabhani-Gebara S. Survey to assess procedures for handling cytotoxic drugs in academic research laboratories in the United Kingdom. Am J Health Syst Pharm 2016; 73:e59-62. [PMID: 26683682 DOI: 10.2146/ajhp150164] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
- Racha Sabbagh Dit Hawasli
- Racha Sabbagh Dit Hawasli, Pharm.D., Ph.D., is Researcher; Reem Kayyali, Ph.D., M.Sc., B.Pharm., MRPharmS, SFHEA, is Associate Professor; Stephen Barton, Ph.D., CSci, CChem, MRSC, is Associate Professor; Georges Osei-Barnieh, M.Pharm., is a student; and Shereen Nabhani-Gebara, Pharm.D., BCOP, is Senior Lecturer, Kingston University London, Kingston upon Thames, England
| | - Reem Kayyali
- Racha Sabbagh Dit Hawasli, Pharm.D., Ph.D., is Researcher; Reem Kayyali, Ph.D., M.Sc., B.Pharm., MRPharmS, SFHEA, is Associate Professor; Stephen Barton, Ph.D., CSci, CChem, MRSC, is Associate Professor; Georges Osei-Barnieh, M.Pharm., is a student; and Shereen Nabhani-Gebara, Pharm.D., BCOP, is Senior Lecturer, Kingston University London, Kingston upon Thames, England
| | - Stephen Barton
- Racha Sabbagh Dit Hawasli, Pharm.D., Ph.D., is Researcher; Reem Kayyali, Ph.D., M.Sc., B.Pharm., MRPharmS, SFHEA, is Associate Professor; Stephen Barton, Ph.D., CSci, CChem, MRSC, is Associate Professor; Georges Osei-Barnieh, M.Pharm., is a student; and Shereen Nabhani-Gebara, Pharm.D., BCOP, is Senior Lecturer, Kingston University London, Kingston upon Thames, England
| | - Georges Osei-Barnieh
- Racha Sabbagh Dit Hawasli, Pharm.D., Ph.D., is Researcher; Reem Kayyali, Ph.D., M.Sc., B.Pharm., MRPharmS, SFHEA, is Associate Professor; Stephen Barton, Ph.D., CSci, CChem, MRSC, is Associate Professor; Georges Osei-Barnieh, M.Pharm., is a student; and Shereen Nabhani-Gebara, Pharm.D., BCOP, is Senior Lecturer, Kingston University London, Kingston upon Thames, England
| | - Shereen Nabhani-Gebara
- Racha Sabbagh Dit Hawasli, Pharm.D., Ph.D., is Researcher; Reem Kayyali, Ph.D., M.Sc., B.Pharm., MRPharmS, SFHEA, is Associate Professor; Stephen Barton, Ph.D., CSci, CChem, MRSC, is Associate Professor; Georges Osei-Barnieh, M.Pharm., is a student; and Shereen Nabhani-Gebara, Pharm.D., BCOP, is Senior Lecturer, Kingston University London, Kingston upon Thames, England.
| |
Collapse
|
8
|
Janes A, Bérard C, Bussières JF. [Not Available]. Can J Hosp Pharm 2016; 69:30-35. [PMID: 26985086 PMCID: PMC4777578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Alexia Janes
- D. Pharm., est assistante à la recherche au Département de pharmacie et Unité de recherche en pratique pharmaceutique, Centre hospitalier universitaire Sainte-Justine, Montréal (Québec)
| | - Cécile Bérard
- est assistante à la recherche au Département de pharmacie et Unité de recherche en pratique pharmaceutique, Centre hospitalier universitaire Sainte-Justine, Montréal (Québec). Elle est aussi candidateD. Pharm. au CHU de Toulouse, Toulouse, France
| | - Jean-François Bussières
- B. Pharm., M. Sc., M. B. A., FCSHP, est chef, Département de pharmacie et Unité de recherche en pratique pharmaceutique, Centre hospitalier universitaire Sainte-Justine, et professeur, Faculté de pharmacie, Université de Montréal, Montréal (Québec)
| |
Collapse
|
9
|
Ambados F, Crea J, Chin M, Lee SG. Preparation Method and Stability of a Temozolomide Suspension: A Pilot Study. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2012.tb00145.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Joe Crea
- Discipline of Public Health, School of Population Health and Clinical Practice; The University of Adelaide
| | | | - Su-Gil Lee
- Discipline of Public Health, School of Population Health and Clinical Practice; The University of Adelaide; Adelaide South Australia
| |
Collapse
|
10
|
Lee SG, Tkaczuk M, Jankewicz G, Ambados F. Surface Contamination from Cytotoxic Chemotherapy Following Preparation and Administration. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2007.tb00763.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
| | | | - Ganyk Jankewicz
- Occupational Hygienist, School of Population Health and Clinical Practice; The University of Adelaide
| | - Fotios Ambados
- The Queen Elizabeth Hospital; Woodville South South Australia
| |
Collapse
|
11
|
|
12
|
Gilbar P. SHPA Standards of Practice for the Provision of Palliative Care Pharmacy Services. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2006.tb00636.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Peter Gilbar
- SHPA Committee of Specialty Practice in Cancer Services
| |
Collapse
|
13
|
SHPA Standards of Practice for the Provision of Oral Chemotherapy for the Treatment of Cancer. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2007.tb00044.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
14
|
SHPA Guidelines for Medicines Prepared in Australian Hospital Pharmacy Departments. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2010.tb00521.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
15
|
SHPA Standards of Practice for the Transportation of Cytotoxic Drugs from Pharmacy Departments. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2007.tb00753.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
16
|
SHPA Standards of Practice for Pharmacy Investigational Drugs Services. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2006.tb00887.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
17
|
Lee SG, Ambados F, TkaczukPhD M, Jankewicz G. Paclitaxel Exposure and its Effective Decontamination. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2009.tb00449.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Michael TkaczukPhD
- Discipline of Public Health; The University of Adelaide; South Australia
| | - Ganyk Jankewicz
- Discipline of Public Health; The University of Adelaide; South Australia
| |
Collapse
|
18
|
O'Leary K, Burke R, Kirsa S. SHPA Standards of Practice for the Distribution of Medicines in Australian Hospitals. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2015. [DOI: 10.1002/j.2055-2335.2006.tb00592.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
| | | | - Sue Kirsa
- Peter MacCallum Cancer Centre; East Melbourne Victoria
| |
Collapse
|
19
|
Affiliation(s)
- Peter J Gilbar
- Committee of Specialty Practice in Oncology The Society of Hospital Pharmacists of Australia; Senior Pharmacist-Oncology/Palliative Care Toowoomba Health Services; Toowoomba Qld 4350 Australia
| |
Collapse
|
20
|
Robertson K, Roberts L, Plummer D, Ede J. Complexity and Workload of Cytotoxic Manufacturing at a Regional Hospital: A Comparative Study. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2012. [DOI: 10.1002/j.2055-2335.2012.tb00168.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - David Plummer
- School of Public Health, Tropical Medicine and Rehabilitation Sciences; James Cook University
| | - Judy Ede
- The Townsville Hospital; Townsville Queensland
| |
Collapse
|
21
|
Green E, Johnston M, Trudeau M, Schwartz L, Poirier S, Macartney G, Milliken D. Safe handling of parenteral cytotoxics: recommendations for ontario. J Oncol Pract 2011; 5:245-9. [PMID: 20856737 DOI: 10.1200/jop.091014] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/09/2008] [Indexed: 11/20/2022] Open
Abstract
In caring for patients with cancer, health care workers may be exposed to cytotoxic agents. Recommendations are needed to mitigate potential risks for cancer and adverse reproductive outcomes associated with exposure.
Collapse
Affiliation(s)
- Esther Green
- Oncology Nursing, Systemic Treatment, and Evidence-Based Care Programs, Cancer Care Ontario; Occupational Health and Safety Department, Toronto General Hospital, University Health Network, Toronto; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton; Pharmacy, Parkwood Hospital, St Joseph's Health Care, London; Division of Neurosurgery, Children's Hospital of Eastern Ontario; and Hematology Department, Ottawa Hospital, Ottawa, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
22
|
Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, Michael M, Hyde S, Booth A, Rushton S. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia Pac J Clin Oncol 2011; 6:220-37. [PMID: 20887505 DOI: 10.1111/j.1743-7563.2010.01321.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The issue of medication safety is highly significant when anti-cancer therapy is used as a treatment modality due to the high potential for harm from these agents and the disease context in which they are being used. These guidelines provide recommendations on the safe prescribing, dispensing and administration of chemotherapy and related agents used in the treatment of cancer. The guidelines represent a multidisciplinary collaboration to standardise the complex process of providing chemotherapy for cancer and to enhance patient safety. These are consensus guidelines based on the best available evidence and expert opinion of professionals working in cancer care. The aim of these guidelines is to assist in the prevention of medication errors and to improve patient safety with respect to the treatment of cancer. This guidance is intended for a multi-disciplinary audience and will have most relevance for medical, nursing and pharmacy staff involved in the complex processes of delivering chemotherapy and associated treatment. The scope of the guidelines includes; all patients and age groups receiving chemotherapy and targeted therapy for the treatment of cancer and cancer therapy administered by any route in both the hospital and home setting. These guidelines should be seen as point of reference for practitioners providing cancer chemotherapy services.
Collapse
Affiliation(s)
- Christine Carrington
- Division of Cancer, Princess Alexandra Hospital/Cancer Control Team, Brisbane, Queensland, Australia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Behan KP, McGovern TL, Dahms K. Not Seeing the Light? JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2010. [DOI: 10.1002/j.2055-2335.2010.tb00543.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
24
|
Siderov J, Kirsa S, McLauchlan R. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. J Oncol Pharm Pract 2009; 16:19-25. [PMID: 19965949 DOI: 10.1177/1078155209352543] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND The potential for staff exposure to antineoplastic agents exists in the workplace despite current recommended safe handling procedures. Reliance on cytotoxic drug safety cabinets (CDSC) to provide total protection from exposure to hazardous drugs is insufficient. Preventing workplace contamination is the best strategy to minimise exposure. PhaSeal is a commercially available system for ensuring the leak-free transfer of hazardous drugs, fitting both the NIOSH and ISOPP definitions of a closed system. To date, there have been no published studies examining the use of a closed system drug transfer device (PhaSeal) under Australian conditions.The purpose of this study is to determine the impact of a closed system drug transfer device on cytotoxic surface contamination in the cytotoxic preparation areas of two Australian metropolitan public hospitals. METHOD This was a pre- and post-intervention study in which chemical contamination was tested at baseline then at five and 12 months after the introduction of the a closed system drug transfer device. Cyclophosphamide was used as a surrogate marker for all cytotoxic drugs. Surface wipe sampling was performed at specified sites within the cytotoxic suite using a standardized technique. Commercial products of cyclophosphamide were also sampled. RESULTS After five months, contamination was reduced in 13 of the 22 sites sampled (59%), with four of these samples showing undetectable levels of contamination. Two other site samples (9%) remained unchanged. The total contamination of surfaces tested was reduced by 24%. After five months hospital 1 withdrew from the study. After 12 months, surface contamination was reduced in 75% of sample sites. The total contamination of surfaces tested was reduced by 68%. The wipes of the external surface of commercial products detected cyclophosphamide contamination. CONCLUSION When used inside a CDSC, the closed system drug transfer device PhaSeal further reduces surface contamination, in some instances to undetectable levels.
Collapse
Affiliation(s)
- Jim Siderov
- Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia.
| | | | | |
Collapse
|
25
|
Lee SG, Jankewicz GJ, Lee NW. Assessing Flucloxacillin Contamination and Decontamination-A Laboratory Study. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2009. [DOI: 10.1002/j.2055-2335.2009.tb00429.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Su-Gil Lee
- Discipline of Public Health, School of Population Health and Clinical Practice; The University of Adelaide
| | - Ganyk J Jankewicz
- Discipline of Public Health, School of Population Health and Clinical Practice; The University of Adelaide
| | - Nae-Woo Lee
- Division of Safety Engineering; Pukyong National University; Busan Korea
| |
Collapse
|
26
|
Barras MA, Green B, Towers KA, Pearce B, Roller L, Brizzi J, Reed BL, Vandenbroucke J, McLachlan G. Letters to the Editor. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2008. [DOI: 10.1002/j.2055-2335.2008.tb00803.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Michael A Barras
- Therapeutic Advisory Service Mater Health Services; South Brisbane Qld 4101
| | - Bruce Green
- School of Pharmacy; The University of Queensland; St Lucia Qld 4072
| | - Kate A Towers
- Pharmacy Department; St Vincent's Hospital; Darlinghurst NSW 2010
| | - Bob Pearce
- Clinical Systems Team; Hunter New England Health; Lambton Heights NSW 2305
| | - Louis Roller
- Department of Pharmacy Practice; Monash University
| | - Joe Brizzi
- Registration and Education; Pharmacy Board of Victoria
| | - Barry L Reed
- Pharmacy Board of Victoria; 381 Royal Parade Parkville Vic. 3052
| | | | | |
Collapse
|
27
|
Bereznicki LR, Jackson SL, Peterson GM, Khan SA, Rao PGM, Rao BHA, Singh D, Bedi TRS, Koju R, Adhikari O, Alam K, Khan GM, Palaian S, Clifford RM, Gilbar P. Letters to the Editor. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2006. [DOI: 10.1002/j.2055-2335.2006.tb00595.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | | | - Gregory M Peterson
- Unit for Medication Outcomes Research and Education; Tasmania School of Pharmacy; Hobart Tas. 7001 Australia
| | | | | | - BH Anand Rao
- Department of Surgery; Kasturba Medical College and Hospital Manipal; India
| | - Dharam Singh
- Pharmacy Department; Peter MacCallum Cancer Centre; East Melbourne Vic. 3002 Australia
| | - TRS Bedi
- Kathmandu University Medical College
| | | | | | - Kadir Alam
- Department of Pharmacy; Kathmandu University; Dhulikhel Nepal
| | - GM Khan
- Department of Pharmacy; Kathmandu University; Dhulikhel Nepal
| | - Subish Palaian
- Department of Pharmacy and Pharmacology; Manipal College of Medical Sciences; Pokhara Nepal
| | - Rhonda M Clifford
- School of Biomedical; Biomolecular and Chemical Sciences University of Western Australia; Crawley WA 6009 Australia
| | - Peter Gilbar
- The Society of Hospital Pharmacists of Australia; Toowoomba Health Services; Toowoomba Qld 4350 Australia
| |
Collapse
|